Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

CAPITAL REDUCTION EFFECTIVE

25 Jul 2023 13:45

RNS Number : 1462H
Impellam Group plc
25 July 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

FOR IMMEDIATE RELEASE

25 July 2023

Impellam Group plc

("Impellam" or the "Company" or the "Group")

CAPITAL REDUCTION EFFECTIVE

Impellam Group plc (AIM: IPEL) previously announced on 27 June 2023 that its shareholders had passed each of the resolutions at the annual general meeting held on that day, which included, among other things: (i) the reduction of the share capital of the Company by the cancellation of 94,822 ordinary shares of GBP 0.01 each in the capital of the Company (the Ordinary Shares); and (ii) the cancellation of GBP 30,121,328 of the share premium account of the Company (the Capital Reduction).

Impellam is now pleased to announce that the High Court of Justice in England and Wales has made an order confirming the Capital Reduction (the Court Order) and that the Court Order has now been registered by the Registrar of Companies in England and Wales. Accordingly, the Capital Reduction has now become effective in accordance with the terms of the Court Order.

The Company announced on 12 April 2022 that it had entered into an offer period. The Ordinary Shares are relevant securities of Impellam Group plc for the purposes of Rule 8 of The City Code on Takeovers and Mergers (the Code). In accordance with Rule 2.9 of the Code, Impellam therefore confirms that it now has in issue 44,848,572 ordinary shares with voting rights. The Company has no ordinary shares held in Treasury. The International Securities Identification Number for Impellam ordinary shares is GB00B8HWGJ55.

Enquiries: for further information, please contact the appropriate individual below.

Impellam Group plc

Julia Robertson, Chief Executive Officer Tel: 01582 692 658

 

Canaccord Genuity Limited

(Nominated Advisor and Sole Broker to Impellam)

Bobbie Hilliam Tel: 020 7523 8150

Emma Gabriel

Thomas Diehl

Note to Editors:

Impellam is a connected group providing global workforce and specialist recruitment solutions. Our 2000 people and market leading brands work across a broad spectrum of industries and job categories throughout North America, the UK and Europe and Asia Pac.

Our award-winning Global Managed Services provide a diverse range of digitally enabled, multi-disciplinary workforce solutions to organisations around the world. We are upper quadrant industry leaders in Managed Service Provision and Services Procurement, and the seventh largest Managed Service Provider in the world with over £4bn SUM (Spend under Management).

Our STEM businesses are specialists in recruiting and engaging talent in the key growth markets of technology, digital, data, science, clinical and engineering and work with clients across all sectors and sizes delivering services that span Managed Services (MSP), Recruitment Process Outsourcing (RPO), Statement of Work (SOW) and specialist recruitment.

Led by our Virtuosos, our capabilities are underpinned by our proprietary digital technology and unique partnerships with market-leading software providers, enabling us to transform and future-proof our services.

We believe in the power of work. Through the power of work, we build better businesses and help people lead more fulfilling lives.

For more information about Impellam Group please visit: www.impellam.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCLELFLXDLXBBL
Date   Source Headline
9th Jan 202310:44 amRNSForm 8.5 (EPT/RI)
9th Jan 202310:31 amRNSRule 2.9 Announcement
9th Jan 202310:30 amRNSTransaction in Own Shares
6th Jan 202312:04 pmRNSForm 8.3 - Impellam Group PLC
6th Jan 202310:30 amRNSForm 8.5 (EPT/RI)
5th Jan 20232:33 pmRNSForm 8.3 - Impellam Group PLC
5th Jan 20239:16 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
4th Jan 20231:31 pmRNSForm 8.3 - Impellam Group PLC
4th Jan 20238:22 amRNSForm 8.5 (EPT/RI)
3rd Jan 20237:00 amRNSForm 8.3 - Impellam Group Plc
30th Dec 202210:01 amRNSForm 8.3 - Impellam Group PLC
29th Dec 202211:10 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
29th Dec 20229:53 amRNSForm 8.3 - Impellam Group PLC
28th Dec 202210:51 amRNSForm 8.5 (EPT/RI)
23rd Dec 20229:37 amRNSForm 8.5 (EPT/RI)
22nd Dec 20227:00 amRNSSpecial Dividend Declaration
14th Dec 20222:55 pmRNSRule 2.9 Announcement
14th Dec 20222:30 pmRNSTransaction in Own Shares
14th Dec 20227:28 amRNSForm 8.5 (EPT/RI)
12th Dec 202210:00 amRNSRule 2.9 Announcement
12th Dec 202210:00 amRNSTransaction in Own Shares
12th Dec 20227:48 amRNSForm 8.5 (EPT/RI)
9th Dec 202211:03 amRNSForm 8.5 (EPT/RI)
8th Dec 202211:25 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
6th Dec 20229:51 amRNSForm 8.5 (EPT/RI)
6th Dec 20227:00 amRNSRule 2.9 Announcement
6th Dec 20227:00 amRNSTransaction in Own Shares
2nd Dec 20224:02 pmRNSRule 2.9 Announcement
2nd Dec 20224:01 pmRNSTransaction in Own Shares
2nd Dec 20227:00 amRNSForm 8.5 (EPT/RI)
1st Dec 202212:01 pmRNSRule 2.9 Announcement
1st Dec 202212:00 pmRNSTransaction in Own Shares
1st Dec 202210:02 amRNSForm 8.5 (EPT/RI)
30th Nov 20227:31 amRNSForm 8.5 (EPT/RI)
30th Nov 20227:01 amRNSRule 2.9 Announcement
30th Nov 20227:00 amRNSTransaction in Own Shares
29th Nov 20227:00 amRNSForm 8.5 (EPT/RI)
28th Nov 202211:01 amRNSForm 8.5 (EPT/RI)
28th Nov 20229:00 amRNSRule 2.9 Announcement
28th Nov 20229:00 amRNSTransaction in Own Shares
25th Nov 20229:05 amRNSForm 8.5 (EPT/RI)
23rd Nov 202210:46 amRNSRule 2.9 Announcement
23rd Nov 202210:45 amRNSTransaction in Own Shares
23rd Nov 202210:13 amRNSForm 8.5 (EPT/RI)
22nd Nov 20229:16 amRNSRule 2.9 Announcement
22nd Nov 20229:15 amRNSTransaction in Own Shares
22nd Nov 20228:03 amRNSForm 8.5 (EPT/RI)
21st Nov 202210:45 amRNSForm 8.5 (EPT/RI)
21st Nov 20227:01 amRNSRule 2.9 Announcement
21st Nov 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.